SLC2A1 and melanoma: On the other hand, GLUT1 and GLUT3 are considered as potentially useful markers for the differentiation of melanoma from nevi, as patients with GLUT1- and GLUT3-positive melanomas had significantly lower survival rate than those who lacked GLUT1 and GLUT3 expression in their melanomas [13, 56, 57].